COMBINED PRESENCE OF THREE MGMT GENE-POLYMORPHISMS IN A GLIOBLASTOMA PATIENT, WHO DEVELOPED SEVERE MYELOSUPPRESSION FOLLOWING TEMOZOLOMIDE CHEMOTHERAPY
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
dc.identifier.other
WOS:000386200200140
dc.description.volume
dc.description.issue
Publisher
OXFORD UNIV PRESS INC
DOI
Abstract
12th Meeting of the European-Association-of-Neuro-Oncology, GERMANY, OCT 12-16, 2016